Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases - Tadolini, Marina; Codecasa, Luigi Ruffo; García-García, José-María; Blanc, François-Xavier; Borisov, Sergey; Alffenaar, Jan-Willem; Andréjak, Claire; Bachez, Pierre; Bart, Pierre-Alexandre; Belilovski, Evgeny; Cardoso-Landivar, José; Centis, Rosella; et al. (The European respiratory journal, 2020)
Keywords: Adult; Aged; Agora; Antitubercular Agents - therapeutic use; Antiviral Agents - therapeutic use; Azithromycin - therapeutic use; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coinfection; Coronavirus Infections - complications; Coronavirus Infections - diagnosis; Coronavirus Infections - drug therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Emigrants and Immigrants; Female; Humans; Hydroxychloroquine - therapeutic use; Life Sciences; Lopinavir - therapeutic use; Lung - diagnostic imaging; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral - complications; Pneumonia, Viral - diagnosis; Pneumonia, Viral - drug therapy; Ritonavir - therapeutic use; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis - complications; Tuberculosis - diagnosis; Tuberculosis - drug therapy; Tuberculosis, Pulmonary - complications; Tuberculosis, Pulmonary - diagnosis; Tuberculosis, Pulmonary - drug therapy